This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayes, M.
Right arrow Articles by Ross, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayes, M.
Right arrow Articles by Ross, R. P.
Agricola
Right arrow Articles by Hayes, M.
Right arrow Articles by Ross, R. P.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, July 2007, p. 4658-4667, Vol. 73, No. 14
0099-2240/07/$08.00+0     doi:10.1128/AEM.00096-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Casein Fermentate of Lactobacillus animalis DPC6134 Contains a Range of Novel Propeptide Angiotensin-Converting Enzyme Inhibitors{triangledown}

M. Hayes,1,2 C. Stanton,1,3 H. Slattery,1 O. O'Sullivan,1 C. Hill,2,3 G. F. Fitzgerald,2,3 and R. P. Ross1,3*

Teagasc Biotechnology Centre, Moorepark Food Research, Fermoy, County Cork, Ireland,1 Department of Microbiology, University College, Cork, Ireland,2 Alimentary Pharmabiotic Centre, Cork, Ireland3

Received 15 January 2007/ Accepted 23 April 2007

This work evaluated the angiotensin-converting-enzyme (ACE)-inhibitory activities of a bovine sodium caseinate fermentate generated using the proteolytic capabilities of the porcine small intestinal isolate Lactobacillus animalis DPC6134 (NCIMB deposit 41355). The crude 10-kDa L. animalis DPC6134 fermentate exhibited ACE-inhibitory activity of 85.51% (±15%) and had a 50% inhibitory concentration (IC50) of 0.8 mg protein/ml compared to captopril, which had an IC50 value of 0.005 mg/ml. Fractionation of the crude L. animalis DPC6134 fermentate by membrane filtration and reversed-phase high-performance liquid chromatography (HPLC) generated three bioactive fractions from a total of 72 fractions. Fractions 10, 19, and 43 displayed ACE-inhibitory activity percentages of 67.53 (±15), 83.71 (±19), and 42.36 (±11), respectively, where ACE inhibition was determined with 80 µl of the fractions with protein concentrations of 0.5 mg/ml. HPLC and mass spectrometry analysis identified 25 distinct peptide sequences derived from {alpha}-, ß-, and {kappa}-caseins. In silico predictions, based on the C-terminal tetrapeptide sequences, suggested that peptide NIPPLTQTPVVVPPFIQ, corresponding to ß-casein f(73-89); peptide IGSENSEKTTMP, corresponding to {alpha}s1-casein f(201212); peptide SQSKVLPVPQ, corresponding to ß-casein f(166-175); peptide MPFPKYPVEP, corresponding to ß-casein f(124133); and peptide EPVLGPVRGPFP, corresponding to ß-casein f(210-221), contained ACE-inhibitory activities. These peptides were chosen for chemical synthesis to confirm the ACE-inhibitory activity of the fractions. Chemically synthesized peptides displayed IC50 values in the range of 92 µM to 790 µM. Additionally, a simulated gastrointestinal digestion confirmed that the ACE-inhibitory 10-kDa L. animalis DPC6134 fermentation was resistant to a cocktail of digestive enzymes found in the gastrointestinal tract.


* Corresponding author. Mailing address: Teagasc, Biotechnology Centre, Moorepark, Fermoy, County Cork, Ireland. Phone: 353 (0) 2542229. Fax: 353 (0) 2542340. E-mail: paul.ross{at}teagasc.ie

{triangledown} Published ahead of print on 4 May 2007.


Applied and Environmental Microbiology, July 2007, p. 4658-4667, Vol. 73, No. 14
0099-2240/07/$08.00+0     doi:10.1128/AEM.00096-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Gagnaire, V., Jardin, J., Jan, G., Lortal, S. (2009). Invited review: Proteomics of milk and bacteria used in fermented dairy products: From qualitative to quantitative advances. J DAIRY SCI 92: 811-825 [Abstract] [Full Text]